Michael Lefenfeld Net Worth & Insider Trades
Michael Lefenfeld - Director, Immunome Inc
What is Michael Lefenfeld's Net Worth?
The current estimated net worth of Immunome Inc's Director, Michael Lefenfeld, is estimated to be about $108.44K . Michael Lefenfeld owns about 26,872 units of Immunome Inc common stock. In the last 3 years at Immunome Inc, Michael Lefenfeld has sold an estimated value of $0 worth.
What is Michael Lefenfeld's Past Insider Trading?
Michael Lefenfeld's largest purchase order was 4,650 units , worth over $86.15K on May 26, 2021. In total, Michael Lefenfeld has made about 7 transactions over 3 years of their time at Immunome Inc. Michael Lefenfeld usually trades in June, with the busiest year in 2020, 2021 and 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Michael Lefenfeld
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Michael Lefenfeld's Salary in 2020?
As Director of Immunome Inc, Michael Lefenfeld has a total base salary of $249,385 . Michael Lefenfeld received compensation valued at about $936,806 in 2020 after becoming Director. The vast majority of their compensation came in the form of option awards of $559,694 , other earnings, plans or compensations of $108,204 , and other compensation of $19,523 .
What is Michael Lefenfeld's' Mailing Address?
- Mailing address is Immunome, Inc. 665 Stockton Drive, Suite 300 Exton PA 19341 PA
Immunome Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Purnanand D. Sarma, Ph.D. | 2020 | $435,000 | - | $1,037,560 | $211,561 | $10,881 | $1,695,002 |
| Purnanand D. Sarma, Ph.D. | 2019 | $233,333 | - | - | $81,666 | $24,911 | $339,910 |
| Michael J. Morin, Ph.D. | 2020 | $249,385 | - | $559,694 | $108,204 | $19,523 | $936,806 |
| Michael J. Morin, Ph.D. | 2019 | $220,000 | - | - | $110,000 | $33,770 | $363,770 |
| Sandra G. Stoneman | 2020 | $71,571 | $15,000 | $1,196,828 | $30,632 | $366 | $1,314,397 |
| Sandra G. Stoneman | 2019 | - | - | - | - | - | - |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1472012/000110465921051342/tm2112960d2_def14a.htm
What are Immunome Inc's Past Insider Trades?
Immunome Inc's most recent insider trade came on September 14, 2021 by Michael Rapp who bought 25,962 units worth $518.2K . In the last year, insiders at Immunome Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Michael Rapp, Director, John Lamattina, Director, and Michael Lefenfeld, Director .
Immunome Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||